Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Intravenous Trehalose to Reduce Vascular Inflammation in Acute Coronary Syndrome

NCT03700424 is registered in ClinicalTrials.gov with Mashhad University of Medical Sciences as lead sponsor.

NCT NCT03700424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03700424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Intravenous Trehalose to Reduce Vascular Inflammation in Acute Coronary Syndrome
Lead sponsor
Mashhad University of Medical Sciences
Phase
Phase 2
Overall status
Unknown status
Start date
August 20, 2020
Completion date
August 31, 2022
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome